Cargando…
A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade
On average, there are 3–5 million severe cases of influenza virus infections globally each year. Seasonal influenza vaccines provide limited protection against divergent influenza strains. Therefore, the development of a universal influenza vaccine is a top priority for the NIH. Here, we report a co...
Autores principales: | Corder, Brigette N., Bullard, Brianna L., Poland, Gregory A., Weaver, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589362/ https://www.ncbi.nlm.nih.gov/pubmed/33092070 http://dx.doi.org/10.3390/v12101186 |
Ejemplares similares
-
A Single-Cycle Adenovirus Type 7 Vaccine for Prevention of Acute Respiratory Disease
por: Bullard, Brianna L., et al.
Publicado: (2019) -
Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice
por: Corder, Brigette N., et al.
Publicado: (2019) -
Species D Adenoviruses as Oncolytic Viral Vectors
por: Bullard, Brianna L., et al.
Publicado: (2020) -
Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine
por: Bullard, Brianna L., et al.
Publicado: (2021) -
Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus
por: Bullard, Brianna L., et al.
Publicado: (2021)